Biogen Inc
XHAM:IDP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Biogen Inc
XHAM:IDP
|
US |
|
Pierre et Vacances SA
PAR:VAC
|
FR |
|
A
|
Alamos Gold Inc
NYSE:AGI
|
CA |
|
Icade SA
PAR:ICAD
|
FR |
|
V
|
Vertex Pharmaceuticals Inc
SWB:VX1
|
US |
|
A
|
Asia Medical & Agricultural Laboratory & Research Center PCL
SET:AMARC
|
TH |
|
S
|
SBFC Finance Ltd
BSE:543959
|
IN |
|
ITEQ Corp
TWSE:6213
|
TW |
|
National Bank of Canada
TSX:NA
|
CA |
|
A
|
Adobe Inc
DUS:ADB
|
US |
|
Y
|
Yakult Honsha Co Ltd
OTC:YKLTF
|
JP |
|
E
|
Eurofins Scientific SE
DUS:ESF0
|
LU |
Wall St Price Targets
IDP Price Targets Summary
Biogen Inc
According to Wall Street analysts, the average 1-year price target for IDP is 190.06 EUR with a low forecast of 129.43 EUR and a high forecast of 246.69 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is IDP's stock price target?
Price Target
190.06
EUR
According to Wall Street analysts, the average 1-year price target for IDP is 190.06 EUR with a low forecast of 129.43 EUR and a high forecast of 246.69 EUR.
What is the Revenue forecast for Biogen Inc?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 8 years is 2%.
What is the Operating Income forecast for Biogen Inc?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 8 years is 6%.
What is the Net Income forecast for Biogen Inc?
Projected CAGR
13%
Over the last 13 years, the compound annual growth rate for Net Income has been -1%. The projected CAGR for the next 8 years is 13%.
